| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.3B | $0.2B | $0.2B | $0.3B | $0.2B | $0.2B | $0.1B | $0.1B |
| EPS (Basic) | $5.06 | $4.17 | $3.80 | $4.63 | $0.99 | $0.94 | $0.77 | $0.68 |
| EPS (Diluted) | $5.06 | $4.16 | $3.79 | $4.61 | $0.99 | $0.94 | $0.76 | $0.67 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $17.7B | $17.4B | $16.1B | $14.6B | $15.4B | $11.9B | $8.9B | $8.0B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | $0.6B | $0.7B |
| Total Liabilities | $15.9B | $15.7B | $14.7B | $13.3B | $14.3B | $10.9B | $8.1B | $7.3B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.8B | $1.6B | $1.4B | $1.3B | $1.2B | $1.0B | $0.8B | $0.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.4B | $0.3B | $0.2B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B |
| Investing Cash Flow | $-1.2B | $-0.9B | $-0.2B | $-2.6B | $-1.6B | $-1.4B | $-1.0B | $-0.8B |
| Capital Expenditures | — | — | — | — | — | — | — | $0.0B |
| Financing Cash Flow | $0.0B | $0.9B | $1.3B | $-1.0B | $3.3B | $2.8B | $0.8B | $0.8B |